Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Not applicable Interventional Accepts healthy volunteers Results available

Safety and Effectiveness of NATRELLE® 410 Highly Cohesive, Anatomically Shaped, Silicone-filled X-Style and L-Style Breast Implants

ClinicalTrials.gov ID: NCT01785069

Public ClinicalTrials.gov record NCT01785069. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 2:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Multicenter Study of the Safety and Effectiveness of NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-filled X-style and L-style Breast Implants

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a prospective, multicenter study of the safety and effectiveness of NATRELLE® 410 Highly Cohesive, Anatomically Shaped, Silicone-Filled X-Style and L-Style Breast Implants.

Study identification

NCT ID
NCT01785069
Recruitment status
Terminated
Study type
Interventional
Phase
Not applicable
Lead sponsor
Allergan
Industry
Enrollment
355 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 10, 2012 (Actual)
Primary completion
Nov 30, 2015 (Actual)
Completion
Nov 30, 2015 (Actual)
Last update posted
Jun 25, 2020

2012 – 2015

United States locations

U.S. sites
29
U.S. states
17
U.S. cities
26
Facility City State ZIP Site status
Laurence Berkowitz Campbell California 95008 —
Roy Hong Palo Alto California 94301 —
Eric Bachelor Pleasanton California 94566 —
Gregory Liebscher Colorado Springs Colorado 80919 —
Scott Spear Washington D.C. District of Columbia 20007 —
Calvin Peters Orlando Florida 32801 —
Walter Erhardt Albany Georgia 31701 —
James Namnoum Atlanta Georgia 30342 —
Janet Turkle Carmel Indiana 46032 —
Julene Samuels Louisville Kentucky 40205 —
Timothy Mickel Monroe Louisiana 71201 —
John Renucci Grand Rapids Michigan 49503 —
Steven Morris Midland Michigan 48640 —
Charles Nathan Chesterfield Missouri 63005 —
Herluf Jr. Lund Chesterfield Missouri 63005 —
Patricia McGuire Creve Coeur Missouri 63141 —
Perry Johnson Omaha Nebraska 68118 —
Peter Hyans Berkeley Heights New Jersey 07922 —
Peter Hetzler Little Silver New Jersey 07739 —
Caroline Glicksman Sea Girt New Jersey 08750 —
Tracy Pfeifer Great Neck New York 10028 —
Lloyd Gayle New York New York 10021 —
Raymond Isakov Cleveland Ohio 44195 —
Craig Colville Toledo Ohio 43615 —
Frank Barone Toledo Ohio 43623 —
Mary Gingrass Nashville Tennessee 37203 —
Patrick Maxwell Nashville Tennessee 37212 —
Jeffrey Friedman Houston Texas 77030 —
Thomas Blanchard Newport News Virginia 23606 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01785069, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 25, 2020 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01785069 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →